Shandong Langnuo Pharmaceutical

Shandong Langnuo Pharmaceutical is a comprehensive pharmaceutical enterprise based in Jinan, China, specializing in the research, development, and production of high-end Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company focuses on small molecule therapeutics across several critical therapeutic areas, including cardiovascular health, endocrinology, and anti-infectives. Langnuo is recognized for its expertise in complex chemical synthesis and the production of generic versions of major global drugs such as Rivaroxaban and Sitagliptin. Their manufacturing facilities are built to international GMP standards, enabling them to serve both the domestic Chinese market and international clients. By integrating R&D with large-scale production, the company aims to provide high-quality, affordable medication solutions globally.